Safety, Pharmacokinetics, Pharmacodynamics, and Activity of Navitoclax, a Targeted High Affinity Inh...
Safety, Pharmacokinetics, Pharmacodynamics, and Activity of Navitoclax, a Targeted High Affinity Inhibitor of BCL-2, in Lymphoid Malignancies
About this item
Full title
Author / Creator
Wilson, Wyndham H. , O’Connor, Owen A. , Czuczman, Myron S. , LaCasce, Ann S. , Gerecitano, John F. , Leonard, John P. , Tulpule, Anil , Dunleavy, Kieron , Xiong, Hao , Chiu, Yi-Lin , Cui, Yue , Busman, Todd , Elmore, Steven W. , Rosenberg, Saul H. , Krivoshik, Andrew P. , Enschede, Sari H. and Humerickhouse, Rod A.
Journal title
Language
English
Formats
More information
Alternative Titles
Full title
Safety, Pharmacokinetics, Pharmacodynamics, and Activity of Navitoclax, a Targeted High Affinity Inhibitor of BCL-2, in Lymphoid Malignancies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3025495
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3025495
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(10)70261-8
